ArthroCare Receives FDA Clearance to Market Magnum^® PI Knotless Implant System

All-PEEK Version of Magnum 2 Implant Provides Surgeons with Non-Metallic Option

AUSTIN, Texas--(BUSINESS WIRE)--April 26, 2007--ArthroCare Corp. (Nasdaq:ARTC) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its Magnum PI Knotless Implant System, which utilizes implants made of polyetheretherketone (PEEK) for the attachment of soft tissue to bone.

The Magnum PI Knotless Implant System provides surgeons who prefer non metallic anchors with a radiolucent elastic plastic (PEEK) anchor product line which utilizes the OPUS^® platform's proven technology and operating principles.

"Receiving clearance from the FDA to market the Magnum PI is a great next step for our OPUS collection of products," said Jack Giroux, President of ArthroCare Sports Medicine. "ArthroCare is providing clinically proven tools orthopedic surgeons need to achieve fast, simple solutions to challenging fixation problems in the shoulder and elsewhere. We've now expanded the range of surgical options to include non-metallic, PEEK anchors. It's something that many of the surgeons have been asking for, and it's great to be able to deliver such an exciting and innovative product."

Giroux also said that the Magnum PI Knotless Implant System can be used in shoulder-related procedures such as rotator cuff repairs and in Achilles tendon repair in the foot, among several other indications. He explained that ArthroCare's knotless implant systems are designed to enable trained physicians to perform such surgeries faster and easier.